Saili Medical: The company has the "HISILINKI" smart brain science and neuromorphic research platform.

An investor asked Sure Medical whether the company and its affiliated and controlling companies have any business or products related to brain-computer interfaces or the treatment of brain diseases. Sure Medical stated on the interactive platform that the company's "Haisi Lingxi" brain science and neuromorphic research intelligence platform is a national key project jointly initiated by the company's subsidiary Haisi Taike Medical Technology Co., Ltd. and the First Affiliated Hospital of Zhejiang University School of Medicine. Supported by the National Key Research and Development Program of the Ministry of Science and Technology "2030 Brain Science and Neuromorphic Research" and the key special project of the National Health Commission, the platform focuses on the field of mental disorders such as depression, bipolar disorder, ADHD, etc., building a domestic AI-based digital diagnosis and comprehensive disease management system for mental disorders based on serious medicine. The platform deeply integrates Huawei's Ascend computing power and DeepSeek large models, integrates more than 10 years of clinical data and authoritative medical consensus, and constructs a "prevention-intervention-rehabilitation" full-chain closed loop, covering three core scenes of AI-assisted diagnosis, AI digital therapy, and scientific research queue. Through knowledge graph and domain large model technology, personalized treatment plan design is achieved, accurately matching patient needs, significantly improving diagnostic and therapeutic efficiency.